Oxytocin Bolus Versus Infusion in Elective Cesarean Section"

• Status: Not yet recruiting
• Trial end date: 2023-12-15
• Target enrollment: 0
• Participant gender: Female

Summary

Bolus administration of oxytocin is superior to infusion in time to achieving adequate uterine tone.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Stony Brook University
• Treatments: Oxytocin

Criteria

Inclusion Criteria:

• Parturients between the ages of 18 to 45 with singleton pregnancies

• Undergoing elective cesarean section under spinal anesthesia

• American Society of Anesthesia (ASA) physical status class I or II

• Patients must be able to provide written informed consent

Exclusion Criteria:

• Parturients in labor or ruptured membranes

• Multiple gestation

• Risk factors predisposing to uterine atony (history of placenta previa, preeclampsia, diabetes mellitus macrosomia, hydramnios, bleeding diathesis, uterine fibroids)

• History of uterine atony or postpartum hemorrhage

• History of inherited or acquired coagulation disorders, thrombocytopenia (platelet count <100), or anemia (hemoglobin < 8)

• History of allergy to oxytocin

• Patients not alert and orientated to person, place, and date. Patient must have, in the investigator's opinion, the physical and mental capacity to answer survey questions